Antibodies 2013, 2(2), 193-208; doi:10.3390/antib2020193
Review

In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments

1 Genetics and Development Division, Toronto Western Research Institute, MCL-6-415, 399 Bathurst Street, Toronto M5T 2S8, Ontario, Canada 2 Department of Physiology, Faculty of Medicine, University of Toronto, Toronto M5S 1A8, Ontario, Canada 3 Department of Ophthalmology, Faculty of Medicine, University of Toronto, Toronto M5S 1A8, Ontario, Canada
* Authors to whom correspondence should be addressed.
Received: 4 February 2013; in revised form: 25 March 2013 / Accepted: 29 March 2013 / Published: 11 April 2013
(This article belongs to the Special Issue Single-Domain Antibody)
PDF Full-text Download PDF Full-Text [397 KB, uploaded 11 April 2013 16:11 CEST]
Abstract: Single chain variable domain (Fv) fragments (scFv) are powerful tools in research and clinical settings, owing to better pharmacokinetic properties compared to the parent monoclonal antibodies and the relative ease of producing them in large quantities, at low cost. Though they offer several advantages, they suffer from lower binding affinity and rapid clearance from circulation, which limits their therapeutic potential. However, these fragments can be genetically modified to enhance desirable properties, such as multivalency, high target retention and slower blood clearance, and as such, a variety of scFv formats have been generated. ScFvs can be administered by systemic injection for diagnostic and therapeutic purposes. They can be expressed in vivo through viral vectors in instances where large infection rates and sustenance of high levels of the antibody is required. ScFvs have found applications as tools for in vivo loss-of-function studies and inactivation of specific protein domains, diagnostic imaging, tumor therapy and treatment for neurodegenerative and infectious diseases. This review will focus on their in vivo applications.
Keywords: scFv; recombinant antibodies; in vivo expression; adeno-associated virus (AAV); immunotherapy

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Monnier, P.P.; Vigouroux, R.J.; Tassew, N.G. In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments. Antibodies 2013, 2, 193-208.

AMA Style

Monnier PP, Vigouroux RJ, Tassew NG. In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments. Antibodies. 2013; 2(2):193-208.

Chicago/Turabian Style

Monnier, Philippe P.; Vigouroux, Robin J.; Tassew, Nardos G. 2013. "In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments." Antibodies 2, no. 2: 193-208.

Antibodies EISSN 2073-4468 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert